Activity of radium-223 therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) as third line therapy H. Dresler,D. Sarid, I. Kushnir,A. Peer,E. Rosenbaum,V. Neiman,K. Rouvinov,R. Berger,D. KeizmanEuropean Urology Supplements(2019)引用 0|浏览49暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要